We are live on ! Find out more
EC

EcoR1 Capital Portfolio holdings

AUM $2.34B
1-Year Est. Return 204.53%
This Fund
S&P 500
This Quarter Est. Return
+13.25%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$915M
AUM Growth
-$18.6M
Cap. Flow
-$44.1M
Cap. Flow %
-4.82%
Top 10 Hldgs %
78.79%
Holding
44
New
14
Increased
4
Reduced
5
Closed
14

Top Buys

1
SRRK icon
Scholar Rock
SRRK
+$50.1M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$35M
3
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$25.1M
4
UBX
Unity Biotechnology
UBX
+$24.6M
5
KZR
Kezar Life Sciences
KZR
+$22.2M

Top Sells

1
ARRY
Array Biopharma Inc
ARRY
+$49.8M
2
WVE icon
Wave Life Sciences
WVE
+$45M
3
ASND icon
Ascendis Pharma A/S
ASND
+$23.6M
4
APLS
Apellis Pharmaceuticals
APLS
+$23.4M
5
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$22.7M

Sector Composition

1 Healthcare 93.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APTX
26
DELISTED
Aptinyx Inc. Common Stock
APTX
$992K 0.11%
+41,037
New +$878K
INFI
27
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$787K 0.09%
+412,000
New +$832K
AGIO icon
28
Agios Pharmaceuticals
AGIO
$2.38B
– –
-172,952
Closed -$14.1M
AKBA icon
29
Akebia Therapeutics
AKBA
$370M
– –
-1,425,000
Closed -$13.6M
APLS
30
DELISTED
Apellis Pharmaceuticals
APLS
– –
-1,056,348
Closed -$23.4M
DNLI icon
31
Denali Therapeutics
DNLI
$3.64B
– –
-325,000
Closed -$6.4M
GERN icon
32
Geron
GERN
$924M
– –
-350,000
Closed -$1.49M
GILD icon
33
Gilead Sciences
GILD
$164B
– –
0
– –
PTGX icon
34
Protagonist Therapeutics
PTGX
$8.89B
– –
-1,083,567
Closed -$9.31M
RYTM icon
35
Rhythm Pharmaceuticals
RYTM
$7.52B
– –
-318,564
Closed -$6.34M
SYBX
36
DELISTED
Synlogic
SYBX
– –
-46,667
Closed -$6.57M
URGN icon
37
UroGen Pharma
URGN
$1.95B
– –
-402,300
Closed -$20M
ATYR
38
aTyr Pharma
ATYR
$53.3M
– –
-279,855
Closed -$10.6M
LUMO
39
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
0
– –
KIN
40
DELISTED
Kindred Biosciences, Inc.
KIN
– –
-248,680
Closed -$2.15M
FPRX
41
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-1,240,470
Closed -$21.3M
DOVA
42
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
– –
-429,729
Closed -$11.7M
ARRY
43
DELISTED
Array Biopharma Inc
ARRY
– –
-3,049,312
Closed -$49.8M
CELG
44
DELISTED
Celgene Corp
CELG
– –
0
– –
1
2

Similar funds

G
GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
CC
Capital Counsel New York $2.35B AUM 21.34% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $2.33B AUM 92.42% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.33B AUM 20.04% 1-Year Est. Return
MFAM
Motley Fool Asset Management Alexandria, Virginia $2.33B AUM 21.93% 1-Year Est. Return